Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trabecular bone response to injectable calcium phosphate (Ca-P) cement.

E M Ooms1, J G C Wolke, J P C M van der Waerden

  • 1Department of Biomaterials, College of Dental Science, University Medical Center Nijmegen, P. O. Box 9101, 6500 HB, The Netherlands.

Journal of Biomedical Materials Research
|May 10, 2002
PubMed
Summary

This study evaluated a new injectable calcium phosphate cement implanted in goat trabecular bone. The cement was mixed in three liquid-to-powder ratios and implanted for varying durations. Histological and X-ray analyses showed the cement remained stable and promoted new bone formation without inflammation. The material demonstrated osteotransductive properties, where it was resorbed by osteoclast-like cells and replaced by new bone. No significant differences were found between the tested ratios. The results suggest this cement could serve as a biocompatible and osteoconductive bone substitute in orthopedic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Third-generation modular mandible endoprosthesis in Macaca fascicularis.

International journal of oral and maxillofacial surgery·2020
Same author

Calcium phosphate cements: Optimization toward biodegradability.

Acta biomaterialia·2020
Same author

Vitamin D Deficiency Is Associated With Longer Hospital Stay And Lower Functional outcome After Total Knee Arthroplasty.

Acta orthopaedica Belgica·2018
Same author

A Novel Thermoresponsive Gel as a Potential Delivery System for Lipoxin.

Journal of dental research·2018
Same author

Spheroid formation and stemness preservation of human periodontal ligament cells on chitosan films.

Oral diseases·2018
Same author

A theranostic dental pulp capping agent with improved MRI and CT contrast and biological properties.

Acta biomaterialia·2017

Area of Science:

  • Biomaterials in orthopedic surgery
  • Bone regeneration research
  • Calcium phosphate cement development

Background:

Current research in orthopedic biomaterials seeks materials that integrate with bone without adverse reactions. Prior studies have established that calcium phosphate cements can be biocompatible and osteoconductive. However, gaps remain in understanding how these materials behave in trabecular bone environments. No prior work had resolved whether injectable cements could maintain structural integrity while promoting bone growth. This uncertainty motivated the investigation of a new Ca-P cement formulation. The study aimed to address whether such a material could support bone formation without inflammation. It was already known that traditional polymethylmethacrylate cements lack osteotransductive properties. This gap motivated the need to evaluate alternative cements that might better mimic natural bone remodeling. The research also aimed to clarify if liquid-to-powder ratios influence biological outcomes.

Purpose Of The Study:

The study aimed to assess the biological and mechanical behavior of a newly developed injectable calcium phosphate cement when implanted in trabecular bone. The specific problem addressed was whether this material could support bone regeneration while maintaining biocompatibility. The motivation stemmed from the limitations of existing bone cements, which often lack osteotransductive properties. The researchers sought to determine if the cement could integrate with bone without triggering inflammation. They also aimed to evaluate if the cement’s handling properties were suitable for clinical use. The study focused on whether the material could be resorbed and replaced by new bone. The researchers tested the cement at multiple implantation time points to track its long-term effects. This approach allowed them to observe how the material interacted with bone over time.

Keywords:
Bone substitute materialsCalcium phosphate cementOsteotransductive propertiesTrabecular bone regeneration

Frequently Asked Questions

The cement supports bone regeneration through its osteotransductive property, where it is resorbed by osteoclast-like cells and replaced by new bone.

The study found no significant differences in biological outcomes between the three tested liquid-to-powder ratios.

Polymethylmethacrylate cement is a clinically used material, and comparing it allowed the researchers to assess the relative performance of the new Ca-P cement.

Un-decalcified sections preserved bone structure, allowing accurate histological and histomorphometric evaluation of bone apposition and cement resorption.

Related Experiment Videos

Main Methods:

The researchers implanted a calcium phosphate cement into the femoral trabecular bone of goats at multiple time points. The cement was mixed with three different liquid-to-powder ratios to assess handling properties. The cement was applied as a paste and left in situ for 3 days and 2, 8, 16, and 24 weeks. Polymethylmethacrylate cement served as a control for comparison. X-ray diffraction was used to evaluate the cement’s crystalline structure at various stages. Histological sections were prepared from un-decalcified bone samples to assess tissue response. Histomorphometry was performed to quantify bone apposition and cement resorption. The study focused on whether the cement could support new bone formation without adverse reactions.

Main Results:

The cement demonstrated fast setting and good cohesion when exposed to body fluids, indicating favorable handling properties. X-ray diffraction confirmed that the cement formed apatite and remained stable over time. Histological analysis after 2 weeks showed abundant bone apposition on the cement surface. No inflammatory reaction or fibrous encapsulation was observed at this stage. At later time points, a thin layer of bone covered the cement implants. Osteoclast-like cells resorbed parts of the cement while new bone formed in its place. This process demonstrated the material’s osteotransductive property. Histomorphometric analysis found no significant differences between the three liquid-to-powder ratios tested.

Conclusions:

The study demonstrated that the calcium phosphate cement is biocompatible and osteoconductive based on the observed outcomes. The material supported new bone formation without triggering inflammation or fibrosis. The cement’s osteotransductive property was confirmed by the resorption and replacement of the material with new bone. These findings suggest the cement could serve as a suitable bone substitute in clinical settings. The stability of the cement’s apatite structure over time supports its long-term use. The absence of differences between liquid-to-powder ratios indicates consistent performance. The researchers propose that the cement’s properties make it a candidate for orthopedic applications. The findings align with the aim of developing materials that integrate with bone while maintaining structural integrity.

The cement was evaluated at 3 days and 2, 8, 16, and 24 weeks post-implantation to track its biological behavior over time.

The findings suggest the cement is a candidate material for use as a bone substitute due to its biocompatibility, osteoconductivity, and osteotransductive properties.